Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid
Identifieur interne : 002312 ( Main/Exploration ); précédent : 002311; suivant : 002313Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid
Auteurs : A. Loeffler [États-Unis] ; A. Lewitt [États-Unis] ; J. Demaggio [États-Unis] ; L. Juneau [États-Unis] ; E. Milbury [États-Unis] ; R. Matson [États-Unis]Source :
- Journal of Neural Transmission - Parkinson's Disease and Dementia Section [ 0936-3076 ] ; 1995-02-01.
Abstract
Summary: Though depletion of CSF homovanillic acid (HVA) concentration has often been regarded as a direct indicator of dopamine (DA) deficiency in Parkinson's Disease (PD), CSF HVA is normal in mildly affected patients. To explore why, we measured DA and its metabolites in striatum and CSF in rabbits receiving reserpine for 5 days. Reserpine, which depletes striatal DA by disrupting vesicular storage of the neurotransmitter, results in a compensatory increase of DA turnover. In response to a 96% depletion of striatal DA, its catabolic intermediates 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxytyramine (3-MT) decreased 64% and 92% in striatum, although the endproduct, HVA, was unchanged. In contrast, CSF concentrations of HVA and DOPAC increased significantly, though 3-MT and levodopa (LD) were unaltered. A 5-fold rise in striatal LD concentration after reserpine-induced DA depletion provided evidence for enhanced DA synthesis. As in PD, the compensatory increase of DA synthesis after reserpine administration confounds the ability of CSF HVA to reflect DA depletion.
Url:
DOI: 10.1007/BF02252962
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid</title><author><name sortKey="Loeffler, A" sort="Loeffler, A" uniqKey="Loeffler A" first="A." last="Loeffler">A. Loeffler</name></author><author><name sortKey="Lewitt, A" sort="Lewitt, A" uniqKey="Lewitt A" first="A." last="Lewitt">A. Lewitt</name></author><author><name sortKey="Demaggio, J" sort="Demaggio, J" uniqKey="Demaggio J" first="J." last="Demaggio">J. Demaggio</name></author><author><name sortKey="Juneau, L" sort="Juneau, L" uniqKey="Juneau L" first="L." last="Juneau">L. Juneau</name></author><author><name sortKey="Milbury, E" sort="Milbury, E" uniqKey="Milbury E" first="E." last="Milbury">E. Milbury</name></author><author><name sortKey="Matson, R" sort="Matson, R" uniqKey="Matson R" first="R." last="Matson">R. Matson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:580E8356C3EC4678951DC05A1BD774683BB6EE3B</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1007/BF02252962</idno><idno type="url">https://api.istex.fr/document/580E8356C3EC4678951DC05A1BD774683BB6EE3B/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000791</idno><idno type="wicri:Area/Main/Curation">000689</idno><idno type="wicri:Area/Main/Exploration">002312</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid</title><author><name sortKey="Loeffler, A" sort="Loeffler, A" uniqKey="Loeffler A" first="A." last="Loeffler">A. Loeffler</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Clinical Neuroscience Laboratory, Research Building, Room 209, Sinai Hospital, 6767 West Outer Drive, 48235, Detroit, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Lewitt, A" sort="Lewitt, A" uniqKey="Lewitt A" first="A." last="Lewitt">A. Lewitt</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Clinical Neuroscience Laboratory, Research Building, Room 209, Sinai Hospital, 6767 West Outer Drive, 48235, Detroit, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neurology and Psychiatry, Wayne State University School of Medicine, Detroit, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Cellular and Clinical Neuroscience Program, Wayne State University School of Medicine, Detroit, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Demaggio, J" sort="Demaggio, J" uniqKey="Demaggio J" first="J." last="Demaggio">J. Demaggio</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Clinical Neuroscience Laboratory, Research Building, Room 209, Sinai Hospital, 6767 West Outer Drive, 48235, Detroit, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Juneau, L" sort="Juneau, L" uniqKey="Juneau L" first="L." last="Juneau">L. Juneau</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Preclinical Biometrics, Warner Lambert Company, Ann Arbor, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Milbury, E" sort="Milbury, E" uniqKey="Milbury E" first="E." last="Milbury">E. Milbury</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>ESA, Incorporated, Chelmsford</wicri:regionArea><wicri:noRegion>Chelmsford</wicri:noRegion></affiliation></author><author><name sortKey="Matson, R" sort="Matson, R" uniqKey="Matson R" first="R." last="Matson">R. Matson</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>ESA, Incorporated, Chelmsford</wicri:regionArea><wicri:noRegion>Chelmsford</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neural Transmission - Parkinson's Disease and Dementia Section</title><title level="j" type="abbrev">J Neural Transm Gen Sect</title><idno type="ISSN">0936-3076</idno><idno type="eISSN">1435-1463</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1995-02-01">1995-02-01</date><biblScope unit="volume">9</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="45">45</biblScope><biblScope unit="page" to="53">53</biblScope></imprint><idno type="ISSN">0936-3076</idno></series><idno type="istex">580E8356C3EC4678951DC05A1BD774683BB6EE3B</idno><idno type="DOI">10.1007/BF02252962</idno><idno type="ArticleID">Art4</idno><idno type="ArticleID">BF02252962</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0936-3076</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: Though depletion of CSF homovanillic acid (HVA) concentration has often been regarded as a direct indicator of dopamine (DA) deficiency in Parkinson's Disease (PD), CSF HVA is normal in mildly affected patients. To explore why, we measured DA and its metabolites in striatum and CSF in rabbits receiving reserpine for 5 days. Reserpine, which depletes striatal DA by disrupting vesicular storage of the neurotransmitter, results in a compensatory increase of DA turnover. In response to a 96% depletion of striatal DA, its catabolic intermediates 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxytyramine (3-MT) decreased 64% and 92% in striatum, although the endproduct, HVA, was unchanged. In contrast, CSF concentrations of HVA and DOPAC increased significantly, though 3-MT and levodopa (LD) were unaltered. A 5-fold rise in striatal LD concentration after reserpine-induced DA depletion provided evidence for enhanced DA synthesis. As in PD, the compensatory increase of DA synthesis after reserpine administration confounds the ability of CSF HVA to reflect DA depletion.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Michigan</li></region></list><tree><country name="États-Unis"><region name="Michigan"><name sortKey="Loeffler, A" sort="Loeffler, A" uniqKey="Loeffler A" first="A." last="Loeffler">A. Loeffler</name></region><name sortKey="Demaggio, J" sort="Demaggio, J" uniqKey="Demaggio J" first="J." last="Demaggio">J. Demaggio</name><name sortKey="Juneau, L" sort="Juneau, L" uniqKey="Juneau L" first="L." last="Juneau">L. Juneau</name><name sortKey="Lewitt, A" sort="Lewitt, A" uniqKey="Lewitt A" first="A." last="Lewitt">A. Lewitt</name><name sortKey="Lewitt, A" sort="Lewitt, A" uniqKey="Lewitt A" first="A." last="Lewitt">A. Lewitt</name><name sortKey="Lewitt, A" sort="Lewitt, A" uniqKey="Lewitt A" first="A." last="Lewitt">A. Lewitt</name><name sortKey="Matson, R" sort="Matson, R" uniqKey="Matson R" first="R." last="Matson">R. Matson</name><name sortKey="Milbury, E" sort="Milbury, E" uniqKey="Milbury E" first="E." last="Milbury">E. Milbury</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002312 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002312 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:580E8356C3EC4678951DC05A1BD774683BB6EE3B
|texte= Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid
}}
| This area was generated with Dilib version V0.6.23. |  |